Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Reckitt
Reckitt
Activities:
Body Care
Skin Care
Pharmaceutical
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Manufacturing
Kemtile appointed as a single-source supplier by Reckitt
Kemtile, a division of Stonhard, has been appointed as a single-source supplier to design and install a new flooring solution for production area corridors at Reckitt (formerly Reckitt Benckiser) in Nottingham, UK
Design & Build
M+W Group starts building RB’s new Centre for Scientific Excellence in UK
Groundwork has already begun on the R&D Centre in Dansom Lane, Hull, that will provide a GMP development facility and pilot plant
Regulatory
Australian Federal Court finds Reckitt Benckiser made misleading claims about content of its painkillers
Orders Nurofen Specific Pain product range to be removed from retail shelves
Finance
Reckitt Benckiser to spin off its pharmaceuticals business
Will be renamed Indivior and continue to concentrate on treatments for opioid addiction
You need to be a subscriber to read this article.
Click here
to find out more.
Regulatory
Competition Law is catching pharma companies out
With major multinationals paying a high price for illegal and corrupt market activities, Paul Henty and Rory Ashmore, of legal firm Speechly Bircham, review the underlying causes and the risks
Media
Reckitt Benckiser licenses Atrigel Technology from QTL
<p>Reckitt Benckiser Pharmaceuticals Inc, based in Richmond, VA, has set up a licensing agreement with QLT USA, for Atrigel sustained-release drug delivery technology.</p>
Subscribe now